Greg Freiherr, Industry Consultant
Greg Freiherr, Industry Consultant

Greg Freiherr has reported on developments in radiology since 1983. He runs the consulting service, The Freiherr Group.

Blog | Greg Freiherr, Industry Consultant | Radiology Imaging | October 19, 2016

How Imaging Could Change Medical Ethics

imaging, medical ethics

Image courtesy of Pixabay

To tell or not to tell? That is the question. It has been asked — and gone unasked — for decades, tracing back to the profoundly improved resolution coming from next generation medical imaging equipment. Spurred by digital sonograms and submillimeter-resolution CTs and MRIs, physicians have questioned whether what they see is really disease. Are abnormalities benign — or are they the early signs of disease that need immediate attention?

Most concerning are incidental findings that appear after a cause of symptoms has been locked down. Should they be acted upon? Should more tests be performed? And at what costs? Patient discomfort, inconvenience, even pain might result. Expenses are sure to mount. And to what end?

Documenting every abnormality from every possible angle has been acceptable to our traditional cost-based, reimbursement system. But what about in the future? Under value-based medicine?

Putting money aside, what about the patient? Precedent already exists for keeping patients in the dark, if they so choose, when it comes to their genetic predisposition to disease. Why can’t radiology provide the same kind of buffer from findings that patients don’t want to know about, especially if those findings are incidental, said radiologist Stella Kang at the NYU School of Medicine in New York City. 

Kang and colleagues point out in their paper that low-risk incidental findings have the potential to drive unnecessary testing and over-treatment with financial, psychological and clinical consequences. The challenge for radiologists, they wrote, is to produce guidelines for handling low-risk incidental findings “for which adverse consequences are unlikely but associated with substantial uncertainty because of the lack of strong evidence on which to base the recommendations.” 

A hierarchy of questions characterizes this issue: Should radiologists lead medicine into a new world where the individual wishes of the patient take precedence? Should they push for the development of guidelines that at least consider the wishes of patients? When crafting these guidelines, how much weight should be given to patient preferences and to clinical data?

It is difficult for patients to be objective in emotional times. Presented with suspicious findings — possible lung nodules or a small kidney tumor — who would say “no” to testing that promises additional, possibly life-saving information. What responsibility do physicians have in guiding the patient in these difficult times?

 

Outcome Research … To the Rescue?

Radiology stands today at a crossroads between serving the patient and lowering costs.  The ideal is to find the right answers with fewer tests and lower costs. The magic bullets for doing so are possible, at least theoretically. Their construction may be based on outcomes research and data mining.

Getting this information will require planning. Broadly based clinical data must be recorded in structured forms so they can be efficiently gathered. Radiology is already moving in this direction through structured reporting. The key will be for those developing data mining tools and those recording the data to buy into common goals. This may be easier said than done.

The greatest amount of data is generated daily as part of routine scanning. This is the database that might provide the most useful information to the practicing radiologist. But, just as these data promise to be most effective, so they may be the most difficult to capture, particularly when mainstream radiologists are pressed to do more in less time. Who has the time to record data according to a preset format? What IT department has the time to set up the data collection scheme? Who will do the actual data mining? And who will draw the conclusions and on what basis?

 

Patient Preferences Matter

Kang and co-authors stated in their paper that the development of guidelines will require “better gauging of patient attitudes and preferences regarding low-risk incidental findings and using patient preferences to inform recommendations for low-risk findings.” When patients prefer strongly not to know about — or act upon — low-risk incidental findings, radiologists and the physicians with whom they work must decide whether to respect those preferences. It will be an unprecedented balancing act and a critically important one to do.

At no time in the history of modern medicine have the stakes been higher. Medical institutions are beginning to creak under the weight of aging populations. And America is only going to get older. The analysis of big data could offer previously elusive insights into the value of imaging.

But it may be the patient’s preference — to know about and act on findings — that makes the difference.

 

Editor's note: This is the third blog in a four-part series on State-of-the-art Radiology. The first blog, "When Will the Greatest Trend in Radiology Happen?" can be found here. The second blog, “The Promise Ahead for Radiology,” can be found here.

Related Content

A patient implanted with the Axonics System can undergo MRI examinations safely with radio frequency (RF) Transmit Body or Head Coil under the conditions outlined in the Axonics MRI Conditional Guidelines.

A patient implanted with the Axonics System can undergo MRI examinations safely with radio frequency (RF) Transmit Body or Head Coil under the conditions outlined in the Axonics MRI Conditional Guidelines.

News | Magnetic Resonance Imaging (MRI) | July 02, 2020
July 2, 2020 — Axonics Modulation Technologies, Inc., a medical technology company that has developed and is commerci
This data represents wave 2 of a QuickPoLL survey conducted in partnership with an imagePRO panel created by The MarkeTech Group (TMTG), regarding the effects of COVID-19 on their business

Getty Images

Feature | Coronavirus (COVID-19) | July 01, 2020 | By Melinda Taschetta-Millane
A 3-D ultrasound system provides an effective, noninvasive way to estimate blood flow that retains its accuracy across different equipment, operators and facilities, according to a study published in the journal Radiology.

Volume flow as a function of color flow gain (at a single testing site). For each row the color flow c-plane and the computed volume flow are shown as a function of color flow gain. The c-plane is shown for four representative gain levels, whereas the computed volume flow is shown for 12–17 steps across the available gain settings. Flow was computed with (solid circles on the graphs) and without (hollow circles on the graphs) partial volume correction. Partial volume correction accounts for pixels that are only partially inside the lumen. Therefore, high gain (ie, blooming) does not result in overestimation of flow. Systems 1 and 2 converge to true flow after the lumen is filled with color pixel. System 3 is nearly constant regarding gain and underestimates the flow by approximately 17%. Shown are mean flow estimated from 20 volumes, and the error bars show standard deviation. Image courtesy of the journal Radiology

News | Ultrasound Imaging | July 01, 2020
July 1, 2020 — A 3-D ultrasound
Researchers reviewed results of prostate biopsies on over 3,400 men who had targets identified on prostate MRI and found that the positive predictive value of the test for prostate cancer was highly variable at different sites
News | Prostate Cancer | July 01, 2020
July 1, 2020 — Prostate MRI is an emerging technology used to identify and guide treatment for...
R2* maps of healthy control participants and participants with Alzheimer disease. R2* maps are windowed between 10 and 50 sec21. Differences in iron concentration in basal ganglia are too small to allow visual separation between patients with Alzheimer disease and control participants, and iron levels strongly depend on anatomic structure and subject age. Image courtesy of Radiological Society of North America

R2* maps of healthy control participants and participants with Alzheimer disease. R2* maps are windowed between 10 and 50 sec21. Differences in iron concentration in basal ganglia are too small to allow visual separation between patients with Alzheimer disease and control participants, and iron levels strongly depend on anatomic structure and subject age. Image courtesy of Radiological Society of North America

News | Magnetic Resonance Imaging (MRI) | July 01, 2020
July 1, 2020 — Researchers using magnetic...
Imaging Artificial Intelligence (AI) provider Qure.ai announced its first US FDA 510(k) clearance for its head CT scan product qER. The US Food and Drug Administration's decision covers four critical abnormalities identified by Qure.ai's emergency room product.
News | Artificial Intelligence | June 30, 2020
June 30, 2020 — Imaging Artificial Intelligence (AI) provider Qure.ai announced its first US FDA 510(k) clearance for
Cardiac MR can offer data above and beyond anatomical imaging, which is the main reason why this system was installed at Baylor Scott White Heart Hospital in Dallas. The system is a dedicated heart MRI scanner.

Cardiac MR can offer data above and beyond anatomical imaging, which is the main reason why this system was installed at Baylor Scott White Heart Hospital in Dallas. The system is a dedicated heart MRI scanner.

News | Pediatric Imaging | June 29, 2020
June 29, 2020 — A type of smart magnetic r...
Thoracic findings in a 15-year-old girl with Multisystem Inflammatory Syndrome in Children (MIS-C). (a) Chest radiograph on admission shows mild perihilar bronchial wall cuffing. (b) Chest radiograph on the third day of admission demonstrates extensive airspace opacification with a mid and lower zone predominance. (c, d) Contrast-enhanced axial CT chest of the thorax at day 3 shows areas of ground-glass opacification (GGO) and dense airspace consolidation with air bronchograms. (c) This conformed to a mosai

Thoracic findings in a 15-year-old girl with Multisystem Inflammatory Syndrome in Children (MIS-C). (a) Chest radiograph on admission shows mild perihilar bronchial wall cuffing. (b) Chest radiograph on the third day of admission demonstrates extensive airspace opacification with a mid and lower zone predominance. (c, d) Contrast-enhanced axial CT chest of the thorax at day 3 shows areas of ground-glass opacification (GGO) and dense airspace consolidation with air bronchograms. (c) This conformed to a mosaic pattern with a bronchocentric distribution to the GGO (white arrow, d) involving both central and peripheral lung parenchyma with pleural effusions (black small arrow, d). image courtesy of Radiological Society of North America

News | Coronavirus (COVID-19) | June 26, 2020
June 26, 2020 — In recent weeks, a multisystem hyperinflammatory condition has emerged in children in association wit
The American College of Radiology (ACR) Center for Research and Innovation (CRI) is pleased to announce the development of the COVID-19 Imaging Research Registry (CIRR), an effort by the ACR CRI and the ACR Data Science Institute in collaboration with the ACR and the Society of Thoracic Radiology (STR). Sharyn Katz, M.D., director of research for thoracic radiology at the University of Pennsylvania, chairs the effort’s multiple-disciplinary steering committee, which includes representation from across the i

Getty Images

News | Coronavirus (COVID-19) | June 25, 2020
June 25, 2020 — The American College of Radiology (ACR) Center for R